Physician profile
Travis S Foxx
NPI 1881680726
$22,942.47
in general payments reported to CMS, 2019-2025
11 companies · $38.88 in 2025
The $38.88 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $44.96 · 2021: $22K · 2022: $364 · 2023: $289 · 2025: $38.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $21,773.58 | 2021-2023 | Ha Minuteman G3-R |
| Abbott Laboratories | $735.88 | 2019-2023 | Proclaim |
| Si-Bone, INC. | $137.45 | 2019 | |
| Genesys Orthopedics Systems, L.L.C. | $81.66 | 2021 | |
| Relievant Medsystems, INC. | $71.77 | 2022 | |
| Avanos Medical | $38.88 | 2025 | Coolief Cooled Radiofrequency |
| Heron Therapeutics, INC. | $27.47 | 2023 | Zynrelef |
| Bioventus LLC | $24.55 | 2021 | |
| Boston Scientific Corporation | $20.29 | 2019 | |
| Baudax Bio INC. | $18.75 | 2020 | |
| Zimmer Biomet Holdings, INC. | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$38,117,360.68 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Foxx listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.